IL129688A0 - Process for preparing substituted pyridines - Google Patents

Process for preparing substituted pyridines

Info

Publication number
IL129688A0
IL129688A0 IL12968897A IL12968897A IL129688A0 IL 129688 A0 IL129688 A0 IL 129688A0 IL 12968897 A IL12968897 A IL 12968897A IL 12968897 A IL12968897 A IL 12968897A IL 129688 A0 IL129688 A0 IL 129688A0
Authority
IL
Israel
Prior art keywords
substituted pyridines
preparing substituted
preparing
pyridines
substituted
Prior art date
Application number
IL12968897A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL129688A0 publication Critical patent/IL129688A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
IL12968897A 1996-11-14 1997-11-03 Process for preparing substituted pyridines IL129688A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3088096P 1996-11-14 1996-11-14
PCT/IB1997/001367 WO1998021184A1 (en) 1996-11-14 1997-11-03 Process for substituted pyridines

Publications (1)

Publication Number Publication Date
IL129688A0 true IL129688A0 (en) 2000-02-29

Family

ID=21856496

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12968897A IL129688A0 (en) 1996-11-14 1997-11-03 Process for preparing substituted pyridines

Country Status (32)

Country Link
US (1) US6291489B1 (xx)
EP (1) EP0938476B1 (xx)
JP (1) JP3510635B2 (xx)
KR (1) KR20000053314A (xx)
CN (1) CN1237160A (xx)
AP (1) AP805A (xx)
AR (1) AR010584A1 (xx)
AT (1) ATE319687T1 (xx)
AU (1) AU4634697A (xx)
BG (1) BG103393A (xx)
BR (1) BR9712951A (xx)
CA (1) CA2270386C (xx)
CO (1) CO4930261A1 (xx)
DE (1) DE69735433D1 (xx)
EA (1) EA199900375A1 (xx)
GT (1) GT199700118A (xx)
HR (1) HRP970612A2 (xx)
ID (1) ID18898A (xx)
IL (1) IL129688A0 (xx)
IS (1) IS5029A (xx)
MA (1) MA24401A1 (xx)
MY (1) MY132507A (xx)
NO (1) NO992296D0 (xx)
OA (1) OA11044A (xx)
PA (1) PA8441401A1 (xx)
PE (1) PE10299A1 (xx)
TN (1) TNSN97172A1 (xx)
TR (1) TR199901063T2 (xx)
UY (1) UY24774A1 (xx)
WO (1) WO1998021184A1 (xx)
YU (1) YU22099A (xx)
ZA (1) ZA9710186B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9909555A (pt) * 1998-04-08 2000-12-19 Novartis Ag Novartis S A Novar Herbicidas
US6090942A (en) * 1998-10-15 2000-07-18 Pfizer Inc. Process and intermediates for a β3 -adrenergic receptor agonist
US6515134B1 (en) 1999-02-16 2003-02-04 Kaneka Corporation Substituted acetylpridine derivatives and process for the preparation of intermediates for optically active beta-3 agonist by the use of the same
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
EP1078924B1 (en) * 1999-07-23 2004-10-20 Pfizer Products Inc. Intermediates and a process for producing beta-adrenergic receptor agonists
US20040265991A1 (en) * 2001-10-17 2004-12-30 Naoaki Taoka Process for preparation of (s)-alpha-halomethylpyridine-methanol derivatives
CA2471646A1 (en) * 2002-02-27 2003-09-04 Yong Tao Processes and intermediates useful in preparing .beta.3-adrenergic receptor agonists
US6864268B2 (en) 2002-02-27 2005-03-08 Pfizer Inc. β3 adrenergic receptor agonists
WO2003072573A1 (en) * 2002-02-27 2003-09-04 Pfizer Products Inc. Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
KR100751163B1 (ko) 2003-05-09 2007-08-22 에프. 호프만-라 로슈 아게 알파-1 아드레날린 작용물질로서의 메틸 인돌 및 메틸피롤로피리딘
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
KR20160129109A (ko) 2008-05-23 2016-11-08 아미라 파마슈티칼스 인코포레이티드 5-리폭시게나아제 활성화 단백질 억제제

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358455A (en) 1980-12-23 1982-11-09 Merck & Co., Inc. Aralkylamindethanol heterocyclic compounds
US5019578A (en) 1987-11-27 1991-05-28 Merck & Co., Inc. β-adrenergic agonists
NZ265692A (en) * 1993-06-14 1997-02-24 Pfizer Indole- and benzofuran- containing hydroxyamines and analogs; pharmaceutical compositions
IL113410A (en) * 1994-04-26 1999-11-30 Merck & Co Inc Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
EP0824519A1 (en) 1995-05-10 1998-02-25 Pfizer Inc. Beta-adrenergic agonists
EP0828712A1 (en) * 1995-05-10 1998-03-18 Pfizer Inc. Beta-adrenergic agonists

Also Published As

Publication number Publication date
CN1237160A (zh) 1999-12-01
ID18898A (id) 1998-05-20
JP3510635B2 (ja) 2004-03-29
AU4634697A (en) 1998-06-03
PE10299A1 (es) 1999-02-10
PA8441401A1 (es) 2000-05-24
OA11044A (en) 2002-02-20
MY132507A (en) 2007-10-31
NO992296L (no) 1999-05-12
KR20000053314A (ko) 2000-08-25
EA199900375A1 (ru) 1999-12-29
CA2270386C (en) 2004-08-03
HRP970612A2 (en) 1998-08-31
GT199700118A (es) 1999-05-05
BR9712951A (pt) 1999-12-07
ZA9710186B (en) 1999-05-12
CA2270386A1 (en) 1998-05-22
UY24774A1 (es) 1998-05-05
EP0938476A1 (en) 1999-09-01
MA24401A1 (fr) 1998-07-01
ATE319687T1 (de) 2006-03-15
JP2000504347A (ja) 2000-04-11
NO992296D0 (no) 1999-05-12
CO4930261A1 (es) 2000-06-27
DE69735433D1 (de) 2006-05-04
YU22099A (sh) 2001-09-28
US6291489B1 (en) 2001-09-18
AR010584A1 (es) 2000-06-28
TNSN97172A1 (fr) 2005-03-15
EP0938476B1 (en) 2006-03-08
AP805A (en) 2000-01-28
BG103393A (en) 2000-07-31
WO1998021184A1 (en) 1998-05-22
AP9701147A0 (en) 1998-01-31
IS5029A (is) 1999-04-16
TR199901063T2 (xx) 1999-08-23

Similar Documents

Publication Publication Date Title
HUP9902419A3 (en) Process for preparing nitrobiphenylene
HUP9603179A3 (en) Process for producing benzyl-ethers
HU9700140D0 (en) Process for producing 0-demethyl-tramadol-enantiomeres
IL119402A0 (en) Process for preparing nicotinamide
IL129688A0 (en) Process for preparing substituted pyridines
HUP9700380A3 (en) Process for producing 4-oxoimidazolinium-salts
HUP0000456A3 (en) Method for preparing cyclopropylamines
HU9700212D0 (en) Process for producing alkyl-chlorides
IL134059A0 (en) Process for preparing aminoarylacetylenes
HUP0003203A3 (en) Process for producing bisindolymalimides
EG23935A (en) Process for preparing eprosartin
EG22077A (en) Process for preparing 4-substituted-ih-indole-3 glyoxamides
HUP9701013A3 (en) Process for producing cephem-and isooxacephem derivatives
IL122454A0 (en) Process for forming bubble-pack
IL126184A0 (en) Process for preparing pentafluoropentanol
GB2317178B (en) Process for preparing 1-chloromethylsilatrane
GB9626570D0 (en) Process for making benzisothiazolin-3-ones
AU4115897A (en) Process for preparing 6-aminocapronitrile
HUP0003060A3 (en) Process for preparing 2-halogenated indan-1-ones
IL133288A (en) Process for preparing 3-isochromanone
GR3030254T3 (en) Process for preparing substituted aminotriazolinones
EP0751112A3 (de) Verfahren zur Herstellung von Arylidensubstituierten Alkylcycloalkanonen
IL125646A (en) Process for preparing N-pyruvyl-L-proline
GB9424890D0 (en) Process for preparing pyrolizine derivatives
HUP9902428A3 (en) Process for preparing 2-(thiosubstituted)-4-haloacetophenones